MORI MATTIA

Mattia
Mori
Professore Associato

Presentation

PI of a medicinal chemistry research groupthat uses advanced computational studies and biophysical methods to investigate and characterize macromolecular targets, as well as small molecules endowed with pharmacological relevance through the interaction with various types of macromolecules.

Office hours

  • Friday from 15:00 to 17:00
    Place: Da definire
    Note: E' consigliabile mandare una mail al docente per fissare appuntamento

Contacts

0577232360 [int.2360],0577232488 [int.2488] (Stanza 10 173),0577232952 [int.2952] (Stanza 10 106 San Miniato)

Curriculum Vitae

Notices

Availability of EXPERIMENTAL thesis works in computational medicinal chemistry, for students of CTF, Pharmacy, Chemical Sciences and Chemistry degree courses.

Availability of COMPILATION thesis works on topics related to medicinal chemistry and drug discovery, for students of CTF, Pharmacy, Chemical Sciences and chemistry degree courses.

For information on the topic and the timeline, please do not hesitate to contact me via email 

Teaching activities

Completion accademic year: 2025/2026

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2023/2024

Completion accademic year: 2024/2025

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2022/2023
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2022/2023

Completion accademic year: 2023/2024

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022

Completion accademic year: 2022/2023

Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2019/2020
Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2019/2020

Completion accademic year: 2021/2022

Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2018/2019
Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2018/2019

Completion accademic year: 2020/2021

Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2017/2018

Research

Ultime pubblicazioni:

  • Sanchez De Blas, B., Temprano, A.G., Cives-Losada, C., Briz, O., Lozano, E., Martinez-Chantar, M.L., et al. (2025). A novel noninvasive test based on near-infrared fluorescent cholephilic probes for hepatobiliary secretory function assessment. BIOMÉDECINE & PHARMACOTHÉRAPIE, 187 [10.1016/j.biopha.2025.118074]. - view more
  • Pastore, V., Frison, J., Pesce, C., Ryzhuk, M., Garofalo, M., Cristoferi, M., et al. (2025). Development of nanovehicles for co-delivery of colistin and ArnT inhibitors. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 675 [10.1016/j.ijpharm.2025.125515]. - view more
  • Ferrera, L., Cappiello, F., Venturini, A., Lu, H., Casciaro, B., Cappella, G., et al. (2025). Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung disease. CELLULAR AND MOLECULAR LIFE SCIENCES, 82(1) [10.1007/s00018-025-05633-9]. - view more
  • Giray, B., Kaya, N., Fiabane, M., Buyuk, A.S., Kucuk, H.B., Sardas, S., et al. (2025). Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents. CURRENT PHARMACEUTICAL DESIGN, 31(32), 2611-2624 [10.2174/0113816128361524250131110036]. - view more
  • Bernardoni, B.L., D'Agostino, I., Siragusa, S., Mori, M., Garavaglia, S., La Motta, C. (2025). A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors. MOLECULAR DIVERSITY [10.1007/s11030-025-11179-6]. - view more